AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Silexion Therapeutics Ltd.

$0.01 -$0.03 (-81.28%)
NASDAQ · 30 Oct 2026 19:34 UTC
Previous Close
$0.01
Day Range
$0.00$0.03
Year Range
$0.00$0.15
Market Cap
4.09K
AVG Volume
57.34K
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-18
Primary Exchange
NASDAQUS
Net Income (USD) · A
-20M-15M-10M-5M05M20212022202320242025
SLXNW Net Income (USD) by year
PeriodNet Income (USD)
2025-11.91M
2024-16.44M
2023-2.35M
2022583.68K
2021-755.66K
Operating Income (USD) · A
-20M-10M010M20M20212022202320242025
SLXNW Operating Income (USD) by year
PeriodOperating Income (USD)
202511.63M
2024-12.57M
2023-2.62M
2022-1.23M
2021-721.11K
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: SLXNW

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 18 Nov 2026.

Silexion Therapeutics Ltd.
SLXNW
Stockpicker

Video analysis: SLXNW

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SLXNW

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.